You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA29
  • Published:  26 September 2001
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Guidance on the use of fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia (PDF 38 KB)

    Published:
    17 October 2002
Back to top